stockcue

DNLI (Denali Therapeutics Inc.): Stockcue Score 57/100 — Mixed profile · Valuation 29/100 · Financial health 85/100 · price $18.62. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s